Skyepharma is an expert CDMO specialized in formulating, developing and producing complex oral dosage forms, with complex and tailor-made modified release profiles.
We offer a full range of services, from early stage development to industrial manufacturing and packaging.
Our scientific expert team, supported by our patented technologies, has a solid track-record of successful development, reformulation and transfer projects.
Our GMP site located in France, FDA, ANVISA, Korean MSDS approved, serve worldwide customers, with a recognized high level of service.